Maecenas pulvinar magna sit amet felis fringilla, nec auctor lectus facilisis. Morbi non velit lectus. Proin velit ex, lacinia at hendrerit ut, cursus sit amet eros. Nulla nec tellus imperdiet, ultrices quam eget, vulputate enim. Cras sed mi at felis porta lobortis et in lacus. Maecenas ac volutpat eros. Maecenas efficitur tellus semper congue ullamcorper. Etiam vulputate metus in efficitur porta. Phasellus non velit ut diam blandit suscipit. Suspendisse tristique facilisis tortor, ut ultrices arcu bibendum at. Quisque accumsan dui dictum, semper massa non, porttitor odio. Nulla sit amet enim neque. Donec magna risus, suscipit ut porttitor quis, hendrerit in purus. Vestibulum velit lorem, bibendum quis semper eu, facilisis vitae mi. Nam eget pellentesque lectus, et hendrerit metus. Maecenas non tristique tortor.
Timely insights and analysis from KFF staff
-
Despite for calls from Republican leaders and anti-abortion organizations for the FDA to act quickly, the Louisiana district court has given the FDA until October 7, 2026, one month before the midterms, to file a report with the status of its review and any updated timeframe for completion. In the meantime, clinicians may continue to… more
-
The Trump administration this week backed off a key element of its Medicare Advantage rate proposal, resulting in billions of dollars in additional payments to private insurers. more
-
Certain insurers must now publicly report specific prior authorization metrics, but the new data offer limited insight, providing no information on what types of services are being approved and denied or why as well as no data on prescription drugs. more
Laurie Sobel 
Jeannie Fuglesten Biniek 
Kaye Pestaina